[What about the long-term renal outcome of premature babies?]

J Bacchetta1, P Cochat

  • 1Centre de référence des maladies rénales rares, service de néphrologie et pharmacologie pédiatriques, hôpital Femme-Mère-Enfant et université de Lyon-1, 69677 Bron cedex, France.

Insights

Long-term kidney outcomes for preterm children are uncertain. Regular monitoring of blood pressure, creatinine, and albuminuria is recommended to detect potential renal issues early in these high-risk populations.

Area of Science:

  • Pediatric Nephrology
  • Neonatology
  • Developmental Origins of Health and Disease

Background:

  • Long-term renal prognosis for preterm children remains largely unknown.
  • The fetal programming theory suggests intrauterine growth restriction (IUGR) may impact adult health, including hypertension and metabolic syndrome.
  • Reduced nephron number in animal models of IUGR highlights potential renal risks.

Purpose of the Study:

  • To emphasize the need for further research into the long-term renal outcomes of preterm children.
  • To advocate for early preventive strategies targeting cardiovascular risks, nutrition, and obesity in preterm and IUGR populations.
  • To propose regular renal parameter monitoring for early detection of abnormalities.

Main Methods:

  • The study reviews existing literature on fetal programming and IUGR.
  • It highlights the importance of monitoring key renal parameters.
  • It suggests a follow-up protocol for preterm children.

Main Results:

  • Preterm birth and IUGR are associated with potential long-term renal consequences.
  • Early intervention and monitoring are crucial for managing risks.
  • Specific parameters like blood pressure, serum creatinine, and urinary albumin/creatinine ratio are key indicators.

Conclusions:

  • Regular renal parameter monitoring is essential for preterm children.
  • Early detection and management can mitigate long-term renal risks.
  • Further research is warranted to fully understand the renal prognosis in this population.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...